Title : DTS-108, a novel peptidic prodrug of SN38: in vivo efficacy and toxicokinetic studies - Meyer-Losic_2008_Clin.Cancer.Res_14_2145 |
Author(s) : Meyer-Losic F , Nicolazzi C , Quinonero J , Ribes F , Michel M , Dubois V , de Coupade C , Boukaissi M , Chene AS , Tranchant I , Arranz V , Zoubaa I , Fruchart JS , Ravel D , Kearsey J |
Ref : Clin Cancer Research , 14 :2145 , 2008 |
Abstract : Meyer-Losic_2008_Clin.Cancer.Res_14_2145 |
ESTHER : Meyer-Losic_2008_Clin.Cancer.Res_14_2145 |
PubMedSearch : Meyer-Losic_2008_Clin.Cancer.Res_14_2145 |
PubMedID: 18381956 |
Meyer-Losic F, Nicolazzi C, Quinonero J, Ribes F, Michel M, Dubois V, de Coupade C, Boukaissi M, Chene AS, Tranchant I, Arranz V, Zoubaa I, Fruchart JS, Ravel D, Kearsey J (2008)
DTS-108, a novel peptidic prodrug of SN38: in vivo efficacy and toxicokinetic studies
Clin Cancer Research
14 :2145
Meyer-Losic F, Nicolazzi C, Quinonero J, Ribes F, Michel M, Dubois V, de Coupade C, Boukaissi M, Chene AS, Tranchant I, Arranz V, Zoubaa I, Fruchart JS, Ravel D, Kearsey J (2008)
Clin Cancer Research
14 :2145